CD274 and breast carcinoma: Wang et al. found that post-surgery intravenous administration of platelets, conjugated to PD-L1 blocking antibodies on the surface via a bifunctional maleimide linker, can reduce recurrence and metastasis, and improve survival in the murine models of breast cancer and melanoma [83].